Investors can sue Novo Nordisk for stock losses

31 July 2026 · 06:20 1 min read Source: The Copenhagen Post

Summary

A judge in New Jersey has ruled that investors can sue Novo Nordisk over losses suffered in 2024, when its stock plummeted over 20 percent following trial results for the weight-loss drug Cagrisema. The lawsuit was raised in January 2025 against Novo Nordisk, Research Director Martin Holst Lange, and then-CEO Lars Fruergaard Jørgensen. The case […]

More news from Jersey → More about science → Region: Europe

Continue at the source

Read the complete news report directly at The Copenhagen Post.

Read the full report ↗